Total Payments
$118,721
2024 Payments
$2,122
Companies
38
Transactions
201
Medicare Patients
16,499
Medicare Billing
$12.4M
Payment Breakdown by Category
Consulting$100,665 (84.8%)
Other$9,321 (7.9%)
Food & Beverage$8,454 (7.1%)
Gifts$175.63 (0.1%)
Education$105.69 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $100,665 | 25 | 84.8% |
| Food and Beverage | $8,454 | 153 | 7.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,500 | 1 | 2.9% |
| Acquisitions | $2,772 | 1 | 2.3% |
| Current or prospective ownership or investment interest | $1,560 | 6 | 1.3% |
| Honoraria | $845.68 | 4 | 0.7% |
| Grant | $500.15 | 1 | 0.4% |
| Gift | $175.63 | 1 | 0.1% |
| Entertainment | $144.43 | 1 | 0.1% |
| Education | $105.69 | 2 | 0.1% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$118,721
195 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Baxter Healthcare | $97,590 | 24 | $0 (2023) |
| US Retina LLC | $4,331 | 13 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $3,617 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $3,370 | 5 | $0 (2022) |
| Genentech USA, Inc. | $977.50 | 28 | $0 (2024) |
| NotalVision | $975.86 | 6 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $959.04 | 27 | $0 (2024) |
| Alcon Laboratories Inc | $733.98 | 6 | $0 (2018) |
| ABBVIE INC. | $696.53 | 7 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $640.00 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,122 | 48 | ABBVIE INC. ($595.38) |
| 2023 | $49,131 | 40 | Baxter Healthcare ($47,700) |
| 2022 | $57,555 | 37 | Baxter Healthcare ($49,890) |
| 2021 | $567.50 | 6 | US Retina LLC ($371.42) |
| 2020 | $550.48 | 5 | US Retina LLC ($206.41) |
| 2019 | $1,707 | 19 | US Retina LLC ($316.00) |
| 2018 | $1,036 | 14 | Alcon Laboratories Inc ($382.92) |
| 2017 | $6,051 | 32 | Valeant Pharmaceuticals North America LLC ($3,617) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Ophthalmology | ||||||
| 12/14/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Ophthalmology | ||||||
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: EYE CARE | ||||||
| 11/12/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $149.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/30/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Ophthalmology | ||||||
| 10/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $107.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/25/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 09/25/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: EYE CARE | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/23/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Ophthalmology | ||||||
| 08/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $102.83 | General |
| Category: Ophthalmology | ||||||
| 08/08/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Ophthalmology | ||||||
| 08/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,955 | 32,276 | $9.8M | $3.1M |
| 2022 | 18 | 4,368 | 16,433 | $9.6M | $3.2M |
| 2021 | 16 | 4,276 | 12,587 | $9.3M | $3.3M |
| 2020 | 18 | 3,900 | 11,424 | $8.3M | $2.9M |
Total Patients
16,499
Total Services
72,720
Medicare Billing
$12.4M
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 299 | 2,274 | $4.5M | $1.6M | 34.6% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 75 | 21,720 | $1.8M | $631,726 | 34.6% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 54 | 753 | $753,000 | $163,203 | 21.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 464 | 1,635 | $899,250 | $158,902 | 17.7% |
| J3490 | Unclassified drugs | Office | 2023 | 44 | 89 | $423,770 | $151,542 | 35.8% |
| 92134 | Imaging of retina | Office | 2023 | 860 | 2,215 | $276,875 | $61,973 | 22.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 28 | 282 | $247,200 | $53,215 | 21.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 379 | 478 | $129,060 | $51,348 | 39.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 468 | 506 | $134,090 | $44,664 | 33.3% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 12 | 360 | $120,960 | $43,330 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 398 | 656 | $131,200 | $38,384 | 29.3% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 13 | 196 | $78,400 | $31,212 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 217 | $58,590 | $18,744 | 32.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 141 | 141 | $44,415 | $13,947 | 31.4% |
| 92250 | Photography of the retina | Office | 2023 | 330 | 444 | $42,180 | $11,968 | 28.4% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 11 | 11 | $20,020 | $7,998 | 39.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 47 | 136 | $20,400 | $7,555 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $20,300 | $7,050 | 34.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 75 | 84 | $15,960 | $5,231 | 32.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 16 | 21 | $3,150 | $767.12 | 24.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 349 | 3,166 | $6.3M | $2.3M | 35.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 59 | 1,361 | $1.1M | $297,610 | 26.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 442 | 1,683 | $925,650 | $162,428 | 17.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 34 | 3,660 | $307,440 | $109,219 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 554 | 1,500 | $187,500 | $96,692 | 51.6% |
About Dr. Robert Wong, MD
Dr. Robert Wong, MD is a Ophthalmology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275699274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Wong, MD has received a total of $118,721 in payments from pharmaceutical and medical device companies, with $2,122 received in 2024. These payments were reported across 201 transactions from 38 companies. The most common payment nature is "Consulting Fee" ($100,665).
As a Medicare-enrolled provider, Wong has provided services to 16,499 Medicare beneficiaries, totaling 72,720 services with total Medicare billing of $12.4M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Austin, TX
- Active Since 12/28/2006
- Last Updated 05/04/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1275699274
Products in Payments
- Hillrom - RetinaVue 700 Imager (Device) $97,590
- PROLENSA (Drug) $3,500
- BEOVU (Drug) $3,370
- Constellation (Device) $1,216
- OZURDEX (Drug) $981.21
- ForeseeHome (Device) $975.86
- EYLEA (Biological) $524.76
- Lucentis (Biological) $524.23
- EYLEA AFLIBERCEPT INJECTION (Biological) $462.21
- Vabysmo (Drug) $438.60
- EYLEA HD (Biological) $406.08
- ACTHAR (Biological) $382.08
- Syfovre (Drug) $363.57
- VABYSMO (Drug) $319.95
- YUTIQ (Drug) $216.26
- Prokera (Device) $204.95
- Izervay (Drug) $189.81
- CLARUS (Device) $175.63
- XIPERE (Drug) $174.83
- NFC-700 (Device) $144.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Austin
Vikram Durairaj, Md, MD
Ophthalmology — Payments: $516,103
Ophthalmology $516,103
Dr. Sheila Barbarino, M.d, M.D
Ophthalmology — Payments: $236,894
Ophthalmology $236,894
Dr. Thomas Walters, Md, MD
Ophthalmology — Payments: $217,539
Ophthalmology $217,539
Chirag Jhaveri, M.d, M.D
Ophthalmology — Payments: $211,408
Ophthalmology $211,408
Dr. Steven Dell, M.d, M.D
Ophthalmology — Payments: $177,840
Ophthalmology $177,840
Dr. Aaron Roller, M.d, M.D
Ophthalmology — Payments: $154,063
Ophthalmology $154,063